ACST (acastipharma.com) Prakiraan wutah bathi resik saben saham ing taun iki

Simbol resmi perusahaan Acasti Pharma (ACST)

Partnerships with research centers to develop inhalations enhance the investment attractiveness of Acasti Pharma (ACST), as illustrated by the annual EPS growth. The value of -6.60 characterizes this valuation parameter. The development of transmucosal drug delivery accelerates the therapeutic effect, while the preparation of data for the regulator regarding the drug ONP-002 completes the company's current innovation cycle in the cardiology sector.

ACST (Acasti Pharma Inc.) riwayat Wutah bathi saben saham ing taun lumaku saka 04.07.2022 nganti 28.10.2024

Rincian metrik keuangan lan pasar acastipharma.com (ACST)

- rega saham lan prakiraan rega para ahli:
Rega Acasti Pharma Inc.|ACST - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar ACST|ACST - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Nilai Akuntansi Saham Acasti Pharma|ACST - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih acastipharma.com|ACST - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Acasti Pharma|ACST - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Acasti Pharma Inc.|ACST - Utang perusahaan|Rasio utang marang aset resik ACST|ACST - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Acasti Pharma|Rasio cepet acastipharma.com
- indikator pendapatan resik lan kelipatan nilai:
ACST - Bathi resik|Proyeksi bathi mangsa ngarep Acasti Pharma|ACST - Pangali P/E|Prakiraan rega marang bathi Acasti Pharma Inc.|ACST - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan ACST|ACST - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Acasti Pharma|ACST - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan acastipharma.com|ACST - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Acasti Pharma
- data pendapatan lan penerimaan dodolan:
ACST - Pendapatan lan volume dodolan|Prakiraan volume dodolan Acasti Pharma Inc.|ACST - Rasio rega marang pendapatan|Rega forward marang dodolan ACST
Analisis dhasar perusahaan:Acasti (ACST)
Produk sing diprodhuksi acastipharma.com

This indicator measures the year-over-year dynamics of earnings per share, reflecting the efficiency of business capitalization and real income growth rates. In the context of Acasti Pharma (ACST), analyzing YoY EPS changes allows for an assessment of how colossal expenditures on cardiology research and patent protection impact final profitability. The stability of this metric determines the fair risk premium amid the uncertainty of clinical trials.

Pesaing utama

REGN: Wutah bathi resik saben siji saham kanggo taun lumaku|IRTC (iRhythm Technologies Inc) - Wutah bathi ing taun lumaku|Lantheus Corp (LNTH) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki MLYS (Mineralys Therapeutics)|HTFL (HeartFlow, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Kestra Medical KMTS|ESPR (Esperion Therapeutics, Inc.) - Dinamika bathi saben saham ing taun lumaku|Amarin Corp - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku AVR (Anteris Technologies Global)|TNYA: Wutah bathi ing taun lumaku|cvrx.com (CVRX) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Milestone Pharmaceuticals Inc.|CRDL: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku HeartBeam Corp (BEAT)|Wutah bathi resik saben saham ing taun iki Tenax Therapeutics Inc TENX|Wutah bathi ing taun lumaku ADGM (Adagio Medical Holdings)|Wutah bathi ing taun lumaku biocardia.com BCDA|Catheter Precision, Inc. - Wutah bathi ing taun lumaku|ABIO - Wutah bathi ing taun lumaku|AVTE: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Verve Therapeutics, Inc.|Wutah bathi saben saham ing taun lumaku Windtree Therapeutics Inc.